Abstract:Induction of pluripotent stem cells from somatic cells by defined factors was shown to be possible only recently, but already several laboratories have made tremendous strive toward improving and understanding the process. Originally, Oct4, Sox2, Klf4, and cMyc were identified as being the combination of genes necessary to induce reprogramming. It was later shown that cMyc was dispensable; however, in its absence the process was less efficient and took a considerably longer period of time to occur. Furthermore, others have shown that the combination of Oct4, Sox2, Nanog, and Lin28 could also induce reprogramming. One major caveat associated with these techniques remains the need for overexpression of several genes using viral systems. Until very recently, most studies were done using integrating viruses such as retroviruses and lentiviruses. This method ensured that the protein of interested would be expressed at a high concentration and for an adequate period of time necessary to induce reprogramming. Up to date, others have now been able to use different nonintegrative method such as adenovirus and plasmid transfection to induce reprogramming. Furthermore, piggyBac transposition was successfully used to induce reprogramming of murine cells. Most importantly, it was recently published that reprogramming can be induced in the absence of virus, with proteins and small molecules. All of the later methods are appealing since they do not require the integration of the virus or plasmid to exert its effect. However, one avenue that would be all the more therapeutically appealing would be to induce reprogramming in the absence of gene overexpression systems, using small molecules to modulate signaling pathways in the somatic cells. A few molecules have already been identified with the ability to either improve the process or replace one or two of the genes deemed necessary for reprogramming. We have screened successfully for compounds that can replace some of these factors, and share the methods developed following these screens.

Generation of transducible versions of transcription factors Oct4 and Sox2

Potential Utility of Cell-Permeable Transcription Factors to Direct Stem Cell Differentiation

Incorporating protein transduction domains (PTD) within recombinant ‘fusion’ transcription factors. A novel strategy for directing stem cell differentiation?

Cellular Reprogramming Employing Recombinant Sox2 Protein

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins.

Generation of Human-Induced Pluripotent Stem Cells in the Absence of Exogenous Sox2

Direct Activation of Human and Mouse Oct4 Genes Using Engineered TALE and Cas9 Transcription Factors.

Conversion of Sox17 into A Pluripotency Reprogramming Factor by Reengineering Its Association with Oct4 on Dna

Reciprocal Transcriptional Regulation of Pou5f1 and Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells

Brief Report: Combined Chemical Treatment Enables Oct4-Induced Reprogramming from Mouse Embryonic Fibroblasts

Cell-free production of transducible transcription factors for nuclear reprogramming

Harnessing Endogenous Transcription Factors Directly by Small Molecules for Chemically Induced Pluripotency Inception.

A Simple and Efficient System for Regulating Gene Expression in Human Pluripotent Stem Cells and Derivatives.

Generation of a Recombinant Stem Cell-Specific Human SOX2 Protein from Escherichia coli Under Native Conditions

Activation of Pluripotency Genes in Human Fibroblast Cells by a Novel Mrna Based Approach

Evaluation of the determinants for improved pluripotency induction and maintenance by engineered SOX17

Using Small Molecules to Improve Generation of Induced Pluripotent Stem Cells from Somatic Cells

Improved retroviral episome transfer of transcription factors enables sustained cell fate modification

Fine-tuning of iPSC derivation by an inducible reprogramming system at the protein level.

Sox Transcription Factors Require Selective Interactions with Oct4 and Specific Transactivation Functions to Mediate Reprogramming

Recombinant Transcription Factors (TFs) Fused to ZEBRA Minimal Transduction Domain (MD) for Modulation of mRNA Transcripts